These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 28850634)

  • 21. Outcome of treatment in young adults with phenylketonuria detected by routine neonatal screening between 1964 and 1971.
    Beasley MG; Costello PM; Smith I
    Q J Med; 1994 Mar; 87(3):155-60. PubMed ID: 8208903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intellectual level (IQ) in heterozygotes for phenylketonuria (PKU). Is the PKU gene also acting by means other than phenylalanine-blood level elevation?
    Thalhammer O; Havelec L; Knoll E; Wehle E
    Hum Genet; 1977 Oct; 38(3):285-8. PubMed ID: 914277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of age-specific phenylalanine levels with intellectual outcome in patients with phenylketonuria.
    Viau KS; Wengreen HJ; Ernst SL; Cantor NL; Furtado LV; Longo N
    J Inherit Metab Dis; 2011 Aug; 34(4):963-71. PubMed ID: 21556836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Children and adolescents with phenylketonuria display fluctuations in their blood phenylalanine levels.
    Feldmann R; Schallert M; Nguyen T; Och U; Rutsch F; Weglage J
    Acta Paediatr; 2019 Mar; 108(3):541-543. PubMed ID: 30047169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intellectual development of the patients of the German Collaborative Study of children treated for phenylketonuria.
    Burgard P; Schmidt E; Rupp A; Schneider W; Bremer HJ
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S33-8. PubMed ID: 8828606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect on intelligence of relaxing the low phenylalanine diet in phenylketonuria.
    Smith I; Beasley MG; Ades AE
    Arch Dis Child; 1991 Mar; 66(3):311-6. PubMed ID: 2025007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of the phenylalanine hydroxylase gene on maternal phenylketonuria outcome.
    Güttler F; Azen C; Guldberg P; Romstad A; Hanley WB; Levy HL; Matalon R; Rouse BM; Trefz F; de la Cruz F; Koch R
    Pediatrics; 2003 Dec; 112(6 Pt 2):1530-3. PubMed ID: 14654659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The IQ of heterozygotes for phenylketonuria (PKU). indication of a blood phenylalanine-independent action of the PKU mutant (author's transl)].
    Thalhammer O; Havelec L; Knoll E; Wehle E
    Wien Klin Wochenschr; 1977 Oct; 89(20):684-6. PubMed ID: 930099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive profile and mental health in adult phenylketonuria: A PKU-COBESO study.
    Jahja R; Huijbregts SCJ; de Sonneville LMJ; van der Meere JJ; Legemaat AM; Bosch AM; Hollak CEM; Rubio-Gozalbo ME; Brouwers MCGJ; Hofstede FC; de Vries MC; Janssen MCH; van der Ploeg AT; Langendonk JG; van Spronsen FJ
    Neuropsychology; 2017 May; 31(4):437-447. PubMed ID: 28318283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropsychological function in mild hyperphenylalaninemia.
    Smith ML; Saltzman J; Klim P; Hanley WB; Feigenbaum A; Clarke JT
    Am J Ment Retard; 2000 Mar; 105(2):69-80. PubMed ID: 10755172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of age at loss of dietary control on intellectual performance and behavior of children with phenylketonuria.
    Holtzman NA; Kronmal RA; van Doorninck W; Azen C; Koch R
    N Engl J Med; 1986 Mar; 314(10):593-8. PubMed ID: 3945244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlates of intelligence test results in treated phenylketonuric children.
    Williamson ML; Koch R; Azen C; Chang C
    Pediatrics; 1981 Aug; 68(2):161-7. PubMed ID: 7267221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intellectual development in 12-year-old children treated for phenylketonuria.
    Azen CG; Koch R; Friedman EG; Berlow S; Coldwell J; Krause W; Matalon R; McCabe E; O'Flynn M; Peterson R
    Am J Dis Child; 1991 Jan; 145(1):35-9. PubMed ID: 1985428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.
    Jahja R; Huijbregts SC; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; van Spronsen FJ
    Mol Genet Metab; 2013; 110 Suppl():S57-61. PubMed ID: 24183792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term follow up of patients with classical phenylketonuria after diet relaxation at 5 years of age. The Paris Study.
    Rey F; Abadie V; Plainguet F; Rey J
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S39-44. PubMed ID: 8828607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural history of phenylketonuria and influence of early treatment.
    Smith I; Wolff OH
    Lancet; 1974 Sep; 2(7880):540-4. PubMed ID: 4140266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The outcome of white matter abnormalities in early treated phenylketonuric patients: A retrospective longitudinal long-term study.
    Mastrangelo M; Chiarotti F; Berillo L; Caputi C; Carducci C; Di Biasi C; Manti F; Nardecchia F; Leuzzi V
    Mol Genet Metab; 2015 Nov; 116(3):171-7. PubMed ID: 26283467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Executive functioning in children and adolescents with phenylketonuria.
    VanZutphen K; Packman W; Sporri L; Needham M; Morgan C; Weisiger K; Packman S
    Clin Genet; 2007 Jul; 72(1):13-8. PubMed ID: 17594394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Summary of findings from the United States Collaborative Study of children treated for phenylketonuria.
    Azen C; Koch R; Friedman E; Wenz E; Fishler K
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S29-32. PubMed ID: 8828605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can untreated PKU patients escape from intellectual disability? A systematic review.
    van Vliet D; van Wegberg AMJ; Ahring K; Bik-Multanowski M; Blau N; Bulut FD; Casas K; Didycz B; Djordjevic M; Federico A; Feillet F; Gizewska M; Gramer G; Hertecant JL; Hollak CEM; Jørgensen JV; Karall D; Landau Y; Leuzzi V; Mathisen P; Moseley K; Mungan NÖ; Nardecchia F; Õunap K; Powell KK; Ramachandran R; Rutsch F; Setoodeh A; Stojiljkovic M; Trefz FK; Usurelu N; Wilson C; van Karnebeek CD; Hanley WB; van Spronsen FJ
    Orphanet J Rare Dis; 2018 Aug; 13(1):149. PubMed ID: 30157945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.